Back to Search
Start Over
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib
- Source :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20)
- Publication Year :
- 2013
- Subjects :
- Cancer Research
medicine.medical_specialty
Lung Neoplasms
Bone Neoplasms
Scarring alopecia
Risk Assessment
Severity of Illness Index
Cicatrix
Gefitinib
Refractory
Ficlatuzumab
Carcinoma, Non-Small-Cell Lung
Biopsy
Severity of illness
Antineoplastic Combined Chemotherapy Protocols
medicine
Carcinoma
Humans
Aged
medicine.diagnostic_test
business.industry
Biopsy, Needle
Antibodies, Monoclonal
Alopecia
medicine.disease
Dermatology
Immunohistochemistry
Oncology
Quinazolines
Female
business
medicine.drug
Follow-Up Studies
Subjects
Details
- ISSN :
- 15277755
- Volume :
- 31
- Issue :
- 20
- Database :
- OpenAIRE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....0a602a73d7340a61ea8480331aed26f1